These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15367856)

  • 1. Glycosylation defects in muscular dystrophies.
    Haliloğlu G; Topaloğlu H
    Curr Opin Neurol; 2004 Oct; 17(5):521-7. PubMed ID: 15367856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.
    Endo T
    Acta Myol; 2005 Oct; 24(2):64-9. PubMed ID: 16550917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.
    Barresi R; Michele DE; Kanagawa M; Harper HA; Dovico SA; Satz JS; Moore SA; Zhang W; Schachter H; Dumanski JP; Cohn RD; Nishino I; Campbell KP
    Nat Med; 2004 Jul; 10(7):696-703. PubMed ID: 15184894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
    Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
    Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Journey into muscular dystrophies caused by abnormal glycosylation.
    Muntoni F
    Acta Myol; 2004 Sep; 23(2):79-84. PubMed ID: 15605948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.
    Stevens E; Carss KJ; Cirak S; Foley AR; Torelli S; Willer T; Tambunan DE; Yau S; Brodd L; Sewry CA; Feng L; Haliloglu G; Orhan D; Dobyns WB; Enns GM; Manning M; Krause A; Salih MA; Walsh CA; Hurles M; Campbell KP; Manzini MC; ; Stemple D; Lin YY; Muntoni F
    Am J Hum Genet; 2013 Mar; 92(3):354-65. PubMed ID: 23453667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscular dystrophies due to defective glycosylation of dystroglycan.
    Muntoni F; Brockington M; Godfrey C; Ackroyd M; Robb S; Manzur A; Kinali M; Mercuri E; Kaluarachchi M; Feng L; Jimenez-Mallebrera C; Clement E; Torelli S; Sewry CA; Brown SC
    Acta Myol; 2007 Dec; 26(3):129-35. PubMed ID: 18646561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystroglycan glycosylation and muscular dystrophy.
    Moore CJ; Hewitt JE
    Glycoconj J; 2009 Apr; 26(3):349-57. PubMed ID: 18773291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective glycosylation in muscular dystrophy.
    Muntoni F; Brockington M; Blake DJ; Torelli S; Brown SC
    Lancet; 2002 Nov; 360(9343):1419-21. PubMed ID: 12424008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of defective glycosylation in congenital muscular dystrophy.
    Schachter H; Vajsar J; Zhang W
    Glycoconj J; 2004; 20(5):291-300. PubMed ID: 15229394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein glycosylation in disease: new insights into the congenital muscular dystrophies.
    Martin-Rendon E; Blake DJ
    Trends Pharmacol Sci; 2003 Apr; 24(4):178-83. PubMed ID: 12707004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage.
    Martin PT
    Nat Clin Pract Neurol; 2006 Apr; 2(4):222-30. PubMed ID: 16932553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy.
    Larson AA; Baker PR; Milev MP; Press CA; Sokol RJ; Cox MO; Lekostaj JK; Stence AA; Bossler AD; Mueller JM; Prematilake K; Tadjo TF; Williams CA; Sacher M; Moore SA
    Skelet Muscle; 2018 May; 8(1):17. PubMed ID: 29855340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
    Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
    Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAPPC11-related muscular dystrophy with hypoglycosylation of alpha-dystroglycan in skeletal muscle and brain.
    Munot P; McCrea N; Torelli S; Manzur A; Sewry C; Chambers D; Feng L; Ala P; Zaharieva I; Ragge N; Roper H; Marton T; Cox P; Milev MP; Liang WC; Maruyama S; Nishino I; Sacher M; Phadke R; Muntoni F
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12771. PubMed ID: 34648194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity.
    Jimenez-Mallebrera C; Torelli S; Feng L; Kim J; Godfrey C; Clement E; Mein R; Abbs S; Brown SC; Campbell KP; Kröger S; Talim B; Topaloglu H; Quinlivan R; Roper H; Childs AM; Kinali M; Sewry CA; Muntoni F
    Brain Pathol; 2009 Oct; 19(4):596-611. PubMed ID: 18691338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscular dystrophy: central nervous system alpha-dystroglycan glycosylation defects and brain malformation.
    Fagiolari G; Cappellini A; Cagliani R; Prelle A; Lucchini V; Fortunato F; Locatelli F; Crugnola V; Comi GP; Bresolin N; Moggio M; Lamperti C
    J Child Neurol; 2010 Mar; 25(3):312-20. PubMed ID: 19633331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP).
    Thornhill P; Bassett D; Lochmüller H; Bushby K; Straub V
    Brain; 2008 Jun; 131(Pt 6):1551-61. PubMed ID: 18477595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zebrafish models for human FKRP muscular dystrophies.
    Kawahara G; Guyon JR; Nakamura Y; Kunkel LM
    Hum Mol Genet; 2010 Feb; 19(4):623-33. PubMed ID: 19955119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan.
    Manya H; Yamaguchi Y; Kanagawa M; Kobayashi K; Tajiri M; Akasaka-Manya K; Kawakami H; Mizuno M; Wada Y; Toda T; Endo T
    J Biol Chem; 2016 Nov; 291(47):24618-24627. PubMed ID: 27733679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.